---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-071792"
form_type: "8-K"
ticker: "CARM"
cik: "0001485003"
company_name: "Carisma Therapeutics Inc."
filed_at: "2024-06-14T23:59:59+00:00"
generated_at: "2026-06-01T04:17:55.287020+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Carisma grants retention options: 125K shares CEO, 85K each CFO/CSO, vesting over 2 years

## Summary
- CEO Steven Kelly receives option for 125,000 shares; CFO Richard Morris and CSO Michael Klichinsky each get 85,000 shares.
- Exercise price equals closing price on June 17, 2024 grant date; options vest in two equal installments on first and second anniversaries.
- Grants approved by Compensation Committee to incentivize retention during implementation of revised operating plan.
- Company intends to make additional retention grants to other employees under the same plan.

## SEC filing metadata
- accession: 0001104659-24-071792
- form_type: 8-K
- ticker: CARM
- cik: 0001485003
- company_name: Carisma Therapeutics Inc.
- filed_at: 2024-06-14T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1485003/000110465924071792/0001104659-24-071792-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1485003/000110465924071792/tm2417340d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-071792
- JSON: https://secwatch.observer/filing/0001104659-24-071792.json
- Plain text: https://secwatch.observer/filing/0001104659-24-071792.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.